Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zimmer Biomet Holdings Inc (NYSE:ZBH)

118.13
BATS BZX Real-Time Price
As of 3:09pm ET
 -7.19 / -5.74%
Today’s Change
95.63
Today|||52-Week Range
133.21
+14.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$25.2B

Company Description

Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products, sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products. The company operates through three geographical segments: America, Europe and Asia Pacific. The Americas segment comprises principally of the U.S. and includes other North, Central and South American markets. The Europe segment comprises principally of Europe and includes the Middle East and African markets. The Asia Pacific segment comprises primarily of Japan and includes other Asian and Pacific markets. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Contact Information

Zimmer Biomet Holdings, Inc.
345 East Main Street
Warsaw Indiana 46580
P:(574) 267-6131
Investor Relations:
(574) 371-8042

Employees

Shareholders

Other institutional45.91%
Mutual fund holders44.14%
Individual stakeholders13.34%

Top Executives

David C. DvorakPresident, Chief Executive Officer & Director
Adrian FureySenior VP-Global Operations & Logistics
Daniel P. FlorinChief Financial Officer & Senior Vice President
David J. KunzVP-Global Quality, Clinical & Regulatory Affairs
Chad F. PhippsSecretary, Senior Vice President & General Counsel